Skip to main content
Clinical Trials/NCT01834482
NCT01834482
Completed
Not Applicable

A Randomized, Open-label Evaluation of KetoCal® in Initial Combination With the Modified Atkins Diet for the Dietary Management of Intractable Adult Epilepsy.

Johns Hopkins University1 site in 1 country80 target enrollmentMarch 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Epilepsy
Sponsor
Johns Hopkins University
Enrollment
80
Locations
1
Primary Endpoint
Ketosis
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The modified Atkins diet (MAD) has been shown to be effective in treating children and adults with medically resistant seizures. A recent study in children showed that the use of KetoCal® once per day in addition to the MAD appeared to be beneficial when used during the first month. The investigators hypothesize that including a daily KetoCal® liquid tetrapak with one meal during the initial month of the MAD will produce urinary ketosis in more adult patients than the MAD alone and will lead to greater seizure reduction.

Registry
clinicaltrials.gov
Start Date
March 2013
End Date
September 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adults ages \>17 years.
  • At least weekly seizures (or 4 per month). All seizure types allowed.
  • Tried at least two anticonvulsants.

Exclusion Criteria

  • Unwilling to restrict carbohydrates
  • Significantly underweight (Body Mass Index \<18.5)
  • Prior use of the modified Atkins diet for ≥ 2 days
  • Prior use of KetoCal® at any time for any duration
  • Use of the ketogenic diet within the past year
  • Kidney disease
  • History of hypercholesterolemia (total cholesterol \> 300 mg/dl) or hypertriglyceridemia (triglycerides \> 200 mg/dl)
  • Metabolic or mitochondrial disorder
  • Pregnancy or breastfeeding
  • Lactose intolerance or milk allergy

Outcomes

Primary Outcomes

Ketosis

Time Frame: 1 month

Time to urinary ketosis in days will be recorded and whether or not patients achieve serum ketosis at 1 month and 2 months.

Secondary Outcomes

  • Seizure reduction(2 months)
  • Study completion rate(2 months)
  • Tolerability and taste(2 months)
  • Side effects(2 months)

Study Sites (1)

Loading locations...

Similar Trials